Ma’koseh, M., Abufara, A., Tamimi, F., Khader, R., Salem, L., Salama, O., … Faiyoumi, B. (2019). Should CNS IPI Change the Practice of Medical Oncologists in Treatment of Diffuse Large B Cell Lymphoma? A Single Center Experience. In Clinical Lymphoma Myeloma and Leukemia (Vol. 19, pp. S255–S256). Elsevier BV. https://doi.org/10.1016/j.clml.2019.07.166

Ma’koseh, Mohammad, Alaa’ Abufara, Faris Tamimi, Rnad Khader, Lana Salem, Osama Salama, Yacob Saleh, and Baha Faiyoumi. “Should CNS IPI Change the Practice of Medical Oncologists in Treatment of Diffuse Large B Cell Lymphoma? A Single Center Experience.” In Clinical Lymphoma Myeloma and Leukemia, 19:S255–56. Elsevier BV, 2019. https://doi.org/10.1016/j.clml.2019.07.166.

Ma’koseh M, Abufara A, Tamimi F, Khader R, Salem L, Salama O, et al. Should CNS IPI Change the Practice of Medical Oncologists in Treatment of Diffuse Large B Cell Lymphoma? A Single Center Experience. In: Clinical Lymphoma Myeloma and Leukemia. Elsevier BV; 2019. p. S255–6.

Ma’koseh, Mohammad, et al. “Should CNS IPI Change the Practice of Medical Oncologists in Treatment of Diffuse Large B Cell Lymphoma? A Single Center Experience.” Clinical Lymphoma Myeloma and Leukemia, vol. 19, Elsevier BV, 2019, pp. S255–56. Crossref, doi:10.1016/j.clml.2019.07.166.

Ma’koseh M, Abufara A, Tamimi F, Khader R, Salem L, Salama O, Saleh Y, Faiyoumi B. Should CNS IPI Change the Practice of Medical Oncologists in Treatment of Diffuse Large B Cell Lymphoma? A Single Center Experience. Clinical Lymphoma Myeloma and Leukemia. Elsevier BV; 2019. p. S255–S256.